Ignite Creation Date:
2024-05-06 @ 12:36 PM
Last Modification Date:
2024-10-26 @ 1:01 PM
Study NCT ID:
NCT03800381
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2019-01-03
Brief Title:
Adequacy of the New Pediatric IsoniazidRifampinPyrazinamide HRZ Tablet
Sponsor:
Organization:
University of Florida
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Ethylenediaminetetraacetic acid EDTA plasma and whole blood deoxyribonucleic acid DNA
Enrollment Count:
92
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 53298 |
Who Masked List: